Risk of incident type 2 diabetes with romosozumab versus denosumab in patients with osteoporosis: A global real-world cohort study. // Diabetes & Metabolism. – URL: https://www.sciencedirect.com/science/article/pii/S1262363626000820?dgcid=rss_sd_all
Risk of incident type 2 diabetes with romosozumab versus denosumab in patients with osteoporosis: A global real-world cohort study. Diabetes & Metabolism. https://www.sciencedirect.com/science/article/pii/S1262363626000820?dgcid=rss_sd_all
“Risk of incident type 2 diabetes with romosozumab versus denosumab in patients with osteoporosis: A global real-world cohort study.” Diabetes & Metabolism.
@article{article3197,
title = {Risk of incident type 2 diabetes with romosozumab versus denosumab in patients with osteoporosis: A global real-world cohort study},
journal = {Diabetes \& Metabolism},
url = {https://www.sciencedirect.com/science/article/pii/S1262363626000820?dgcid=rss_sd_all}
}